# Measuring Ambulation, Motor, and Behavioral Outcomes With Post-Stroke Fluoxetine in Tanzania

> **NCT03728153** · PHASE2 · COMPLETED · sponsor: **Massachusetts General Hospital** · enrollment: 34 (actual)

## Conditions studied

- Acute Stroke
- Stroke, Ischemic

## Interventions

- **DRUG:** Fluoxetine 20 MG Oral Tablet

## Key facts

- **NCT ID:** NCT03728153
- **Lead sponsor:** Massachusetts General Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-11-26
- **Primary completion:** 2021-01-06
- **Final completion:** 2021-01-06
- **Target enrollment:** 34 (ACTUAL)
- **Last updated:** 2022-05-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03728153

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03728153, "Measuring Ambulation, Motor, and Behavioral Outcomes With Post-Stroke Fluoxetine in Tanzania". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT03728153. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*